Three cases of severe adolescent asthma treated with mepolizumab: lung function trajectories

Real-world experience with mepolizumab for pediatric asthma is still limited. We report 3 patients who were treated with mepolizumab for severe adolescent asthma. Two patients, a 12-year-old boy and a 14-year-old girl, responded well to mepolizumab and showed apparent improvement in lung function fr...

Descripción completa

Detalles Bibliográficos
Autores principales: Hoshi, Miyuki, Matsunaga, Mayumi, Nogami, Kazutaka, Hamada, Kana, Kobori, Taiga, Kainuma, Keigo, Nagao, Mizuho, Fujisawa, Takao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Asia Pacific Association of Allergy, Asthma and Clinical Immunology 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7203436/
https://www.ncbi.nlm.nih.gov/pubmed/32411578
http://dx.doi.org/10.5415/apallergy.2020.10.e13

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7203436/
https://www.ncbi.nlm.nih.gov/pubmed/32411578
http://dx.doi.org/10.5415/apallergy.2020.10.e13

Ejemplares similares